For many people, this experience points to treatment-resistant depression. If your medication no longer works, you’re not alone — and it does not mean your depression is untreatable.
You started your antidepressant with hope. Maybe it worked for a while — then it stopped. The fog is back. The heaviness is back. Now you’re wondering what went wrong.
The answer is often not you — it’s that your treatment needs to change.
When Antidepressants Stop Working in Treatment-Resistant Depression
This experience is so common it has a clinical name: antidepressant tachyphylaxis, sometimes called “poop-out syndrome.” Research estimates that roughly one in three people with depression do not achieve full relief from their first antidepressant. Many more find that a medication that worked well for years gradually loses its effect.
This happens for several reasons. Your brain chemistry shifts over time. Life stressors change. Hormonal fluctuations — especially in women — can alter how medications are metabolized. None of this means your depression is untreatable. It means your treatment plan needs to evolve with you.
What Is Treatment-Resistant Depression?
Treatment-resistant depression (TRD) is generally defined as depression that has not responded adequately to at least two different antidepressants tried at the right dose for the right length of time. According to the National Institute of Mental Health, roughly 30% of people with major depressive disorder fall into this category.
TRD is not a personal failure. It is a recognized medical condition with a growing number of targeted treatments designed specifically for it.
New Treatments for Treatment-Resistant Depression in 2026
Until recently, the options for treatment-resistant depression were limited to trying yet another antidepressant, adding a second medication on top, or pursuing electroconvulsive therapy (ECT). That landscape has shifted meaningfully.
SPRAVATO (esketamine nasal spray) was approved by the FDA as the first monotherapy — meaning a standalone treatment, not just an add-on — specifically for treatment-resistant depression in adults. Unlike traditional antidepressants that target serotonin and take weeks to build up, esketamine acts on the brain’s glutamate system and can produce noticeable improvement within hours to days for some patients. It is administered in a certified clinical setting under supervision.
At-home neuromodulation also reached a milestone when the FDA cleared the first at-home brain stimulation device for moderate to severe major depressive disorder in December 2025. Manufactured by Flow Neuroscience, this wearable headset uses transcranial direct current stimulation (tDCS) and can be prescribed by a clinician for use at home — expanding access to patients who cannot easily travel to a clinic for repeated sessions.
These developments do not replace antidepressants for everyone. Traditional SSRIs and SNRIs remain effective first-line treatments for many people. But they do mean that patients who have been stuck for months or years now have medically validated alternatives worth discussing with their provider.
5 Signs of Treatment-Resistant Depression You Should Not Ignore
Do not wait until you’re in crisis to speak up. Consider scheduling a medication review if:
- You’ve been on the same medication for more than a year with only partial improvement
- Your symptoms have returned after a period of feeling better
- You’re experiencing significant side effects that affect your quality of life
- You’ve tried two or more antidepressants without sustained relief
- Your depression is interfering with work, relationships, or daily functioning
Treatment-Resistant Depression Care at HM Psych in Louisiana
At HM Psych LLC in Bogalusa, Louisiana, medication management is not a quick prescription and a wave goodbye. Our psychiatric providers take time to understand your full history — what you’ve tried, what helped, what didn’t, and what’s changed in your life — before making any recommendations.
We look at your current medication, possible interactions, dosing, and whether newer options might be a better fit for your specific presentation. For patients with treatment-resistant depression, we discuss all appropriate options and help you understand what each one involves so you can make an informed decision about your care.
You Don’t Have to Keep Settling for “Mostly Okay”
Depression is not a condition you should have to manage indefinitely at a low simmer. If your current treatment isn’t giving you the life you want, that’s not the end of the road — it’s a signal to try a different path.
Reach out to HM Psych LLC to schedule a medication evaluation. We serve patients in Bogalusa and across Louisiana, with telehealth options available.
References
- National Institute of Mental Health. Depression. https://www.nimh.nih.gov/health/topics/depression
- U.S. Food & Drug Administration. FDA Approves New Indication for Spravato for Treatment-Resistant Depression. https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-new-indication-spravato-treatment-resistant-depression
- LifeStance Health. New Depression Treatments in 2026. https://lifestance.com/blog/new-depression-treatments-2026/
- PharmaLive. Novel therapies will spur incremental growth in depression treatment in 2025. https://www.pharmalive.com/novel-therapies-spur-incremental-growth-depression-treatment-2025